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Summary 
Active nuclear import of protein is controlled by nu- 
clear localization signals (NLSs), but nuclear export is 
not understood well. Nuclear trafficking of the catalytic 
(C) subunit of cAMP-dependent protein kinase (cAPK) 
is critical for regulation of gene expression. The heat- 
stable inhibitor (PKI) of cAPK contains a nuclear export 
signal (NES) that triggers rapid, active net extrusion 
of the C-PKI complex from the nucleus. This NES (resi- 
dues 35-49), fused or conjugated to heterologous pro- 
teins, was sufficient for rapid nuclear export. Hy- 
drophobic residues were critical. The NES is a slightly 
weaker signal than the SV40 NLS. A sequence con- 
taining only residues 37-46, LALKLAGLDI, is also suf- 
ficient for nuclear export. This is an example of a pro- 
tein-based NES having no obvious association with 
RNA. A similar sequence, LQLPPLERLTL, from Rev, 
an RNA-binding protein of HIV-1, also is an NES. 
Introduction 
Selective targeting of proteins within cells requires the 
macromolecules to bear sorting determinants. Signal se- 
quences for protein trans]50rt into endoplasmic reticulum 
(ER), mitochondria, lysosomes, and chloroplasts (for re- 
views, see Walter and Johnson, t994; Schwarz and Neu- 
pert, 1994; Kornfeld and Mellman, 1989; Smeekens et al., 
1990) are well documented. The exchange of macromole- 
cules between cytoplasm and nucleus is different from 
transport into other organelles because of the presence 
of stable pores in the nuclear envelope. Nuclear pore com- 
plexes, consisting of perhaps 1000 proteins in 60-100 sep- 
arate species, provide aqueous channels with a functional 
diameter of 9-10 nm. Passage of small proteins (<40-60 
kDa) through these pores can occur by diffusion, but the 
import of larger proteins (>40 kDa), as well as RNAs and 
some small proteins, is an active process: it is saturable, 
both temperature and ATP dependent, and causes sub- 
strate accumulation well beyond passive equilibrium. Ac- 
tive import of proteins into the nucleus requires the pres- 
ence of nuclear localization signals (NLSs) (for reviews, 
see Dingwall and Laskey, 1992; Forbes, 1992; Garcia- 
Bustos et al., 1991; Nigg et al., 1991; Silver, 1991, and 
references therein). NLSs do not fit a tight consensus but 
generally fall into two classes: short basic sequences of 
four to seven amino acids (Kalderon et al., 1984) and 
longer bipartite sequences consisting of two stretches of 
basic amino acid sequences separated by ten less- 
conserved spacer ami no acids (Robbins et al., 1991). Pos- 
session of NLSs, while probably necessary, is not suffi- 
cient to ensure nuclear import. The NLSs may be masked 
by binding to other domains or proteins (for reviews, see 
Silver, 1991 ; Nigg, 1990) and may be modulated by phos- 
phorylation (Rihs et al., 1991). Active import of protein into 
the nucleus is believed to occur in two steps: binding to 
the cytoplasmic surface of the nuclear pore complex inde- 
pendent of ATP or GTP, followed by the energy-dependent 
translocation through the nuclear pore complex (New- 
meyer and Forbes, 1988; Richardson et al., 1988). A num- 
ber of cytosolic components have been shown by various 
methods and systems to be involved (Adam and Gerace, 
1991; Moore and Blobel, 1992; for reviews, see Powers 
and Forbes, 1994; Melchior and Gerace, 1995, and refer- 
ences therein). 
The same n uclear pores are also employed in the export 
of macromolecules uch as RNA and protein (Dworetzky 
and Feldherr, 1988; Featherstone t al., 1988), but export 
is much less well understood than import. RNA export is 
probably a signal-mediated active process, because it is 
satu rable and sensitive to low temperature, ATP depletion, 
and wheat germ agglutinin inhibition. Export of RNAs from 
the nucleus also seems to be dependent on the binding 
of other proteins (Bataitle et al., 1990; Dargemont and 
Kuhn, 1992; Zasloff, 1983; for reviews, see Elliott et al., 
1994; Izaurralde and Mattaj, 1995, and references 
therein). Several RNA-binding proteins have been sug- 
gested to be involved in RNA transport: either the tran- 
scription factor TFIIIA or ribosomal protein L5 is required 
for the nuclear export of 5S RNA (Guddat et at., 1990); 
the influenza virus protein M1 is necessary for nuclear 
export of viral RNA-protein complexes (Martin and Hele- 
nius, 1991); the human immunodeficiency virus type l Rev 
protein directly promotes the nuclear export of unspliced 
RNA (Fischer et al., 1994; Meyer and Malim, 1994); and 
Nup145p is required for nuclear export of messenger RNA 
(mRNA) (Fabre et al., t994). It remains unclear whether 
the. export signal for RNA export resides solely on RNA, 
or on protein, or both. The signal required for export of 
RNAs on RNA that has already been identified is the 5' 
monomethylated cap structure for the export of mRNA 
and small nuclear RNA (Dargemont and Kuhn, 1992; 
Hamm and Mattaj, 1990). 
Information on export of proteins from the nucleus is 
even more limited. A number of proteins are known to 
shuttle between nucleus and cytoplasm, some constitu- 
tively and others in response to regulatory signals. These 
include various nucleolar proteins, heat shock protein 
(hsp70), steroid hormone receptors, cAMP-dependent 
protein kinase (cAPK), components of ribonucleoprotein 
(RNP), and NLS-binding protein Nopp140 (reviewed by 
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Goldfarb, 1991; Laskey and Dingwall, 1993, and refer- 
ences therein). They might contribute to coordinating nu- 
clear and cytoplasmic activities in the cell. An important 
question has been whether exit of shuttling proteins from 
the nucleus represents passive diffusion or an active pro- 
cess requiring an export signal. One study on proteins 
shuttling out of Xenopus oocyte nuclei suggested that spe- 
cific domains are required only for nuclear retention and 
that export is a default process not requiring a signal 
(Schmidt-Zachmann et ai., 1993; reviewed by Laskey and 
Dingwall, 1993). However, this result could not exclude 
the possibility that some proteins exit from the nucleus by 
a facilitated, energy-dependent process, as implicated by 
the temperature-dependent xit of pre-mRNA-binding pro- 
tein (heterogeneous nuclear RNP, or hnRNP) from the 
nucleus (Pi6oI-Roma and Dreyfuss, 1992) and the possible 
involvement of NLS in mediating the nuclear export of 
some shuttling proteins (Guiochon et al., 1994). The obser- 
vation that the catalytic subunit (C) of cAPK is actively 
exported from the nucleus by its physiological inhibitor, 
heat-stable protein kinase inhibitor (PKI), first clearly dem- 
onstrated the presence of active nuclear export of proteins 
that exhibit no obvious RNA binding (Fantozzi et al., 1994; 
Wen et al., 1994). 
cAPK exists predominantly as an inactive cytoplasmic 
holoenzyme consisting of two regulatory (R) and two cata- 
lytic (C) subunits. Following an increase in intracellular 
cAMP, the R subunits bind cAMP, resulting in holoenzyme 
dissociation and release of free active C subunit, which 
can then enter the nucleus by passive diffusion (Adams 
et al., 1991; Harootunian et al., 1993; Meinkoth et al., 
1990). PKI alone can enter the nucleus and causes C sub- 
unit to leave the nucleus (Adams et al., 1991; Fantozzi et 
al., 1994). The C-PKI complex exits the nucleus at a rate 
much faster than the free C subunit equilibrates by passive 
diffusion, and the final distribution of C-PKI between cyto- 
plasm and nucleus is far from passive equilibrium. PKI 
does not act by altering the binding of C subunit to nuclear 
or cytoplasmic onstituents, because photobleaching mea- 
surements show that the lateral mobility of C subunit is 
the same in the nucleus and in the cytoplasm regardless 
of the presence or absence of PKI. Also, simple puncture 
of the nuclear envelope immediately allows the complex 
back into the nucleus (Fantozzi et al., 1994). The export 
of C-PKI is temperature and ATP dependent but tolerates 
a large increase in the size of either the C subunit or PKI. 
C-PKI complexes in which C is fused to glutathione S-trans- 
ferase (GST), 140 kDa total, or in which PKI is fused to 
maltose-binding protein (MBP) or GST, 90 kDa and 140 
kDa total, respectively, greatly exceed the size limit for 
diffusion through nuclear pores, yet are rapidly exported. 
These results suggested that the C-PKI complex exposes 
a nuclear export signal (NES) triggering active net extru- 
sion. Further studies showed that the fusion of PKI with 
other proteins, such as GST, resulted in its rapid exit from 
the nucleus even without C, suggesting that the NES re- 
sides solely on PKI (Wen et al., 1994). But the nature and 
composition of this signal were not defined. By con- 
structing chimeric fusion proteins, we have now located 
the region of PKI that encodes the NES. Site-directed mu- 
tagenesis subsequently revealed which amino acids are 
most crucial for this signal. 
Results 
PKla(35-49) Is Sufficient to Direct GST 
from Nucleus to Cytoplasm 
In previous studies, we showed that PKI carries an NES 
and that this signal is likely to reside on the conserved 
residues between PKle and PKII~I, since both forms of 
PKI can export C subunit from the nucleus (Wen et al., 
1994). PKI~ and PKII31 share 41% identity (Van Patten 
et al., 1991). Amino acid sequence alignment (Figure 1) 
reveals that three regions are well conserved. Both PKIe 
and PKI~I contain a pseudosubstrate sequence, RRNAI, 
that mimics the substrate sequence and interacts with C 
subunit with high affinity. However, the PKI inhibitor pep- 
tide (5-24) (reviewed by Walsh et al., 1990), including the 
pseudosubstrate site, is unable to exclude C subunit from 
the nucleus, even though it binds C subunit tightly (Fan- 
tozzi et al., 1994). This suggested that the other two parts 
of PKI might be involved in nuclear export. One region at 
the N-terminus of PKI, from Thr-1 to Glu-4, may function 
as an N-capping motif of an (~ helix as demonstrated by 
nuclear magnetic resonance (NMR) studies (A. Padilla et 
al., personal communication). The other is a hydrophobic 
residue-rich region of unknown function in the middle of 
PKI, from Leu-37 to Thr-49. To locate the NES, PKIc{ was 
systematically truncated from both the N- and the C-ter- 
minus. All deletion mutants were fused with GST (54 kDa 
as dimer) as chimeric proteins. All the fusion proteins were 
expressed in Escherichia coli and purified by use of gluta- 
thione-agarose columns. The purified proteins were then 
labeled with fluorescein isothiocyanate (FITC) and mi- 
croinjected into either the cytoplasm or the nucleus of 
REF52 fibroblasts. Guinea pig immunoglobulin G (IgG), 
which cannot traverse the nuclear envelope, was coin- 
jected to identify the injection sites. As shown previously, 
GST alone spreads throughout the cell irrespective of the 
initial injection site (Wen et al., 1994). However, when it 
is fused to either the N-terminus (GST-PKI) (Wen et al., 
1994) or the C-terminus (PKI-GST) (Figu re 2A) of PKIc~, the 
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Figure 1. Sequence Comparison between 
PKI(~ and PKI[~I 
Identical residues between PKI~ and PKI~I are 
in bold. Residues important for high affinity 
binding to C subunit are underlined. The partial 
restriction enzyme map of PKI cDNA (Thomas 
et al., 1991) is shown above the amino acid 
sequence. 
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Figure 2. PKla(35-49) Is Sufficient to Direct GST from Nucleus to Cytoplasm 
(A) PKI-GST fusion protein is excluded from the nucleus. The C-terminus of full-length PKI was fused to the N-terminus instead of the conventional 
C-terminus of GST. The fusion protein was expressed in E. coli, purified on a glutathione-agarose column, and labeled with FITC. The FITC-labeled 
protein was then coinjected with IgG either into the cytoplasm (a) or the nucleus (c) of REF52 cells. Cells were fixed 30 min after injection and 
stained for the coinjected IgG with an aminomethylcoumarin acetate-conjugated anti-guinea pig antibody (b and d). 
(8) Nuclear export activity is localized to the region of PKI(z from residue 35 to residue 49. (a) and (e) show schematic representations of the GST- 
PKI ([a], GST-25, GST-35, and GST-44) and PKI-GST ([e], 56-GST, 49-GST, and 42-GST) constructs. The N-terminal conserved region is labeled 
1-4, the closed regions represent the PKI inhibitor peptide (5-24), and the hatched regions represent the hydrophobic residue-rich region (37- 
49). The subcellular Iocalizations of fusion proteins were examined 45 min after injection, as described in (A). The nuclear export capacity of these 
proteins is summarized in (a) and (e), where plus indicates fusion proteins that are extruded from the nucleus following nuclear injection and minus 
indicates fusion proteins that remain in the nucleus following nuclear injection. Fluorescence images showing the fate of fusion proteins after 
nuclear injection are shown in (b) (GST-25), (c) (GST-35), (d) (GST-44), (f) (56-GST), (g) (49-GST), and (h) (42-GST). 
(C) PKIc~(35-49) is sufficient for nuclear export. (a), schematic representation of constructs. The oligonucleotides corresponding to sequence (35- 
56, 35-49, or 35-44) were introduced into the site between polyhistidine and GST. Amino acids derived from PK1~(35-49) are boxed; flanking 
sequence from cloning sites are underlined. The subcellular localization of these fusion proteins was determined and summarized as described 
in Figure 2B. Fluorescence emanating from the fusion proteins is shown in (b) (Hs-PKI~(35-56)-GST), (c) (H6-PKI~(35-49)-GST), and (d) (He- 
PKI(z(35-44)-GST). 
(D) The position of the PKla(35-49) sequence in the fusion proteins has little effect on nuclear export. The chimeras were formed by fusing PKk~(35- 
49) either at the beginning (PKla(35-49)-GST), or at the end (GST-PKIc~(35-49)) of GST (a). The subcellular localization of these two fusion 
proteins is shown in (b) (PKI~(35-49)-GST) and (c) (GST-PKI~(35-49)). 
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chimeric proteins are excluded from the nucleus following 
nuclear injection and remain in the cytoplasm for at least 
45 min following cytoplasmic injection. However, the fates 
of the fusion proteins containing truncations in PKla varied 
after nuclear injection (Figure 2B). Both PK1(~(25-75) (Fig- 
ure 2Bb) and PKla(35-75) (Figure 2Bc), with conserved 
residues 37-49 but not 1-4, were sufficient o target the 
GST from the nucleus to the cytoplasm, whereas PKh~(44- 
75) (d), with partial hydrophobic residue conserved re- 
gions, was unable to export GST. Both PK1(~(1-56) (Figure 
2Bf) and PKla(1-49) (Figure 2Bg), but not PK1(~(1-42) (Fig- 
ure 2Bh), were sufficient to export fusion proteins from 
the nucleus following nuclear injection. Taken together, 
these results suggested that the NES is likely to locate 
on the region of PKIc~ between 35-49. 
To confirm whether PKh~(35-49) is sufficient o export 
protein from the nucleus, sequences corresponding to 
PKM residues 35-56, 35-49, or 35-44 were inserted be- 
tween the N-terminal polyhistidine tag (about 23 amino 
acids) and the GST protein. The first two fusions but not 
the third left the nucleus following nuclear injection (Figure 
2C), while all remained in the cytoplasm following cyto- 
plasmic injection (data not shown). Thus, PKI(~ residues 
35-49 are likely to contain the NES. This sequence was 
also effective when fused to the N- or C-terminus of GST 
(Figure 2D). Since the different flanking regions of the GST 
fusion proteins did not affect the cellular distribution follow- 
ing nuclear injection, the NES must come solely from 
PKh~(35-49). Therefore, like an NLS, a single short pep- 
tide is also able to direct protein export from the nucleus. 
PKM(35-49) Is Also Able to Export Deletion R 
Subunit and Its Complex with C Subunit 
from the Nucleus 
We next assessed whether residues 35-49 of PKla are 
sufficient o export proteins other than GST from the nu- 
cleus. The R ~ subunit of cAPK lacking the dimerization 
domain from 1 to 91 was chosen because of its relevance 
to cAMP signaling and potential usefulness. Its subcellular 
distribution is dependent on complexation: alone, it is 
small enough to cross the nuclear envelope, but it is too 
large once it binds the C subunit (Herberg et al., 1994). 
As shown in Figure 3, insertion of PKIc~(35-49) between 
the N-terminal polyhistidine tag and RJ(A1-91) was suffi- 
cient to cause nuclear export (Figure 3b), whereas the 
fusion protein stayed in the cytoplasm following cyto- 
plasmic injection (data not shown). When this fusion pro- 
tein was bound to FITC-labeled C subunit, the complex 
was still exported and excluded from the nucleus (Figure 
3d). In contrast, the analogous fusion H6-PKh~(35-44)- 
R~(A1-91) by itself equilibrated between the cytoplasm 
and the nucleus regardless of injection site (Figure 3c), 
and its complex with C subunit was unable to leave the 
nucleus following nuclear injection (Figure 3e). Therefore, 
PKI(x(35-49), unlike PKIc((35-44), is capable of excluding 
a medium-sized protein, R~(A1-91) (41 kDa), from the nu- 
cleus and directing a larger protein complex (80 kDa with C 
subunit) from the nucleus to the cytoplasm. These results 
confirmed that this region encodes an NES. 
a 
Export 
His 6 PK1(35-49) RI(A1-9] ) 
Hs-PKI(35-44)-R(A1-91 ) ~1 z~,~eL  I ~ 1  
His 8 PKI(35 44) RI(A1-91 ) 
+ 
H6-PKI(35~49)~R(A1-91 ) :C 
H6-PKI(35 44) R(A1-91) : C 
Figure 3. PKh~(35-49) Is Also Sufficient to Export Monomer R' Mutant 
and Its Complex with C Subunit from the Nucleus 
All the constructs are depicted schematically in (a). Oligos of PK1(~(35- 
49) or PKla(35-44) were fused with deletion R' subunit mutant (R(A1 - 
90)) where the dimerization domain from 1-91 was deleted. These 
fusion proteins were expressed in E. coli and purified by using a NF ÷ 
chelate column. The purified proteins were either labeled with FITC 
or complexed with FITC-labeied C subunit and then injected into the 
nucleus. Cells were fixed and stained for coinjected IgG 45 rain after 
injection. (b) and (d) show the distributions ofthe fusion protein H6- 
PKIc~(35-49)-R'(A1-91) alone and its complex with the C subunit, re- 
spectively. (c) and (e) show the distributions ofthe fusion proteins (H6- 
PKla(35-44)-R'(A1-91) alone and complexed with C subunit, respec- 
tively. 
Hydrophobic Residues Are Necessary 
for Nuclear Export 
Once the sequence of an NES had been approximately 
defined, the contributions of individual amino acids were 
then characterized. All the conserved residues were re- 
placed with alanines either individually or together in full- 
length PKIcts. These mutant PKI~s were purified, com- 
plexed with FITC-labeled C subunit, further purified on 
a gel filtration column, and microinjected into either the 
cytoplasm or the nucleus of REF52 cells. IgG was coin- 
jected to document he sites of injection and absence of 
leakage. Mutation of conserved hydrophilic residues of 
PKI~ such as Glu-36, Lys-40, Gin-47, Eys-48, and Thr-49 
to alanine had little impact on the export of the complex 
of FITC-labeled C subunit with PKIm However, when hy- 
drophobic residues such as the leucines at positions 37, 
39, 41, and 44 or the isoleucine at 46 were replaced with 
alanines, significant effects were observed (Figure 4A). 
When Leu-37, Leu-39, and Leu-41 were simultaneously 
changed to alanines, the mutant was no longer able to 
export C subunit from the nucleus. But when nearby pairs 
of leucines (either 37, 39 or 39, 41) were mutated to ala- 
nines, export persisted. Interestingly, when the leucines 
at 37 and 41 were changed to alanines, export was dramat- 
ically impaired. This i  consistent with the secondary struc- 
ture of PKIc~(35-44) determined in solution by NMR, which 
Identification ofa Nuclear Export Signal 
467 
A PK I :F ITC-C  
5 Z4 35 49 
35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 
PK Id  N E L A L K L A G L D I N - - - K T  
PKI~ SDLPLKLEALAVKEDAKT 
P1 
P2  
P3  
P4  
P5  
P6  
P7  
P8  
P9  
P I0  
P I I  
P I2  
P I3  
E x p o r t  
- - A - A - A . . . . . . . . . . .  
A A . . . . . . . . . . . . .  + 
. . . .  A - A . . . . . . . . . . .  + 
- - A - - - A . . . . . . . . . . .  
- - A . . . . . . . . . . . . . . .  + 
. . . .  A . . . . . . . . . . . . .  + 
. . . . . .  A . . . . . . . . . . .  + 
. . . . . .  A - - A . . . . . . . .  
. . . . . . . . .  A A 
. . . . . . . . .  A . . . . . . . .  
. . . . . . . . . . .  A . . . . . .  
B 
10~ , 'HS-PKI (3 5- 4'9)rout '- G ST 
.o 6 - v-v 
v~'NT..v~,, v 
HS-PK I (aa -40) -GST 
2 N ,e  
'e, 
O-o-o-o-e.o_e_o.O.o_o 
0 I I I I I 
20  40  60  80  100  120  
Time (rain) 
Figure 4. Hydrophobic Residues Are Critical for Nuclear Export 
(A) Mutant PKlas where the hydrophobic residues in the region of 
PKI0~(35-49) were replaced with alanines are not able to export FITC- 
labeled C subunit from the nucleus, Mutations were introduced into 
full-length PKI~ as indicated in the schematic representation. The mu- 
tants are named on the left. All mutant PKI proteins were purified 
and complexed with FITC-labeled C subunit. The complex was then 
coinjected with IgG into the nucleu s. The cells were then fixed 30 min 
after injection. The export ability of these proteins is summarized. 
(B) Mutant forms of PK1~(35-49) where the hydropbobic residues were 
replaced with alanines are defective in exporting GST from the nu- 
cleus. The mutant form of PKIc~(35-49), where Leu-41 and Leu-44 
were replaced with alanines, was introduced in the middle (H6- 
PKI~(35-49)m°,-GST) ofthe fusion protein. The fusion proteins con- 
taining wild-type PK1~(35-49) and mutant PKkL(35-49) were injected 
into the nucleus. The distribution of both proteins were assessed in 
living cells as a function of time by quantitative fluorescence imaging. 
indicates that residues 35-44 form an ~ helix with residues 
37 and 41 on the same side, forming a hydrophobic surface 
(A. Padilla et al., personal communication). When Leu-37, 
Leu-39, or Leu-41 was individually changed to alanine, 
no significant effects on the export of C subunit from the 
nucleus were observed. However, replacement of Leu-44 
and Ile-46 with alanine, either individually or together, sig- 
nificantly impaired the ability to exclude the C subunit from 
the nucleus. Mutation of Ile-46 seemed to give the more 
dramatic effect. As might be expected, replacement of 
both Leu-41 and Leu-44 by alanines also blocked export 
(Figure 4A). Therefore, the residues most important for the 
NES are Leu-37, Leu-41, Leu-44, and Ite-46, with Leu-39 
possibly playing a minor role. 
To confirm the importance of these hydrophobic resi- 
dues, similar mutations were introduced into fusions of 
GST with shorter pieces of PKI~. Single mutations L44A 
or i46A or double mutation L41A, L44A prevented nuclear 
export of GST fused to PKIc~(25-75) (data not shown). Like- 
wise, double mutation L41A, L44A significantly impaired 
nuclear export when applied to a PKI~ fragment (35-49) 
placed either at the N-terminus of the fusion protein or 
between a polyhistidine tag and GST (data not shown). 
Quantitative fluorescence imaging of the FITC-labeled 
proteins as a function of time after nuclear injection 
showed that the protein with a mutant NES was exported 
much less quickly and completely than protein with wild- 
type NES (Figure 4B). This further documented the spe- 
cificity of the identified NES encoded by PKI residues 
35-49. 
Chemical Cross-Linking to Synthetic PKla(35-49) 
Causes Extrusion of Bovine Serum Albumin 
and IgG from the Nucleus 
Nuclear localization signals are powerful and autonomous 
enough totrigger nuclear import even when they are chem- 
ically conjugated rather than genetically fused to the trans- 
port substrate. To see whether the NES is equally autono- 
mous, the peptide P(35-49), correspondir~g to PK1~(35- 
49), and the mutant P(35-49)muu with Leu-41 and Leu-44 
replaced by alanines, were synthesized and purified by 
high pressure liquid chromotography (HPLC). Both pep- 
tides were designed with a C-terminal cysteinarnide so 
that they could be coupled to carrier proteins by using 
the heterobifunctional cross-linking reagent succinimi- 
dyl trans-4-(N-maleimidylmethyl)cyclohexane-l-carboxylate 
(SMCC). This reagent linked the C-terminal thiol on the 
peptide with lysine side chains on the marker proteins. 
Bovine serum albumin (BSA) and rabbit IgG were chosen 
as markers, because they are well known to be too large 
to pass through nuclear pores unless actively transported 
(Borer et al., 1989; Goldfarb et al., 1986; Guiochon et al., 
1991; Lanford et al., 1986). Peptide-decorated proteins 
P(35-49)-BSA, P(35-49)mut-BSA, and P(35-49)-IgG con- 
tained 5-10 peptides per molecule of BSA and 1-5 pep- 
tides per molecule of IgG as estimated by the molecular 
weight changes compared with those of uncoupled carrier 
proteins. P(35-49)-BSA and P(35-49)mut-BSA were la- 
beled with FITC either before or after the coupling. Rabbit 
IgG was detected with FITC-conjugated antibody against 
rabbit IgG. After nuclear injection, proteins decorated with 
wild-type peptide were found in the cytoplasm after 45 rain 
(Figures 5a and 5c). When injected into the cytoplasm, 
they remained in the cytoplasm (data not shown). In con- 
trast, uncoupled BSA or IgG or BSA conjugated to the 
mutant peptide was unable to cross the nuclear envelope 
in either direction, and each remained in its initial injection 
site (Figures 5b and 5d). These results show that PKI~(35- 
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Figure 5. A Synthetic Peptide IsAble to Direct BSA and IgG from the 
Nucleus to the Cytoplasm 
A peptide corresponding to the sequence of PK1~(35-49) was synthe- 
sized and conjugated to BSA (a) and IgG (c) with the bifunctional 
cross-linking reagent SMCC. The distribution of BSA conjugated with 
mutant peptide, where the Leu-41 and Leu-44 were replaced with.ala~ 
nines, is shown in (b). The distribution of coinjected uncoupled IgG 
with peptide-conjugated IgG is shown in (d). 
NESmut GST NLS Localization 
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His6 PKl(35-49)mut GST NLS 
49) is an effective NES even when attached by nonphysio- 
logical cross-links to marker proteins far too large to diffuse 
through the nuclear pore. 
NES Is a Slightly Weaker Signal Than NLS 
The identification of the NES raises an interesting ques- 
tion: what will be the cellular fate of a protein containing 
both an NES and an NLS? Fusion proteins were con- 
structed as shown in Figure 6A, with an NES of PKI and 
an NLS of SV40 large T antigen fused respectively to the 
N- and C-terminus of GST(Figure 6Aa). As usual, the distri- 
bution of these proteins was determined after microinjec- 
tion of the FITC-labeled proteins into the cytoplasm (Figure 
6Ab) and nucleus (Figure 6Ac). The fusion protein bearing 
both wild-type NES and NLS was found both in the nucleus 
and cytoplasm (Figures 6Ab and 6Ac), but the nuclear 
fluorescence was brighter than cytoplasmic fluorescence 
(Figure 6A). The final distribution was qualitatively similar, 
regardless of the initial injection site. Quantitative imaging 
showed a final nuclear/cytoplasmic intensity ratio of 3.6 __ 
1.2, only slightly higher than the ratios (1.5-2.5) for macro- 
molecules such as 10 kDa dextran or free C subunit known 
to equilibrate passively across the nuclear envelope (Haro- 
otunian et al., 1993) (Figure 6B). Because the same final 
nuclear/cytoplasmic ratio is quickly attained whether the 
NES-GST-NLS fusion protein is injected into the nucleus 
(initial nuclear/cytoplasmic ratio, >10) or into the cyto- 
plasm (initial ratio, <1), the protein can clearly cross the 
nuclear envelope in either direction and is probably still 
shuttling rapidly in a futile cycle at steady state. As ex- 
pected, when a wild-type NLS was pitted against a mutant 
NES in which alanines replaced the leucines correspond- 
ing to PKI~ positions 41 and 44 (Figure 6Ad), the fusion 
localized essentially exclusively into the nucleus following 
either nuclear (Figure 6Af) or cytoplasmic (Figure 6Ae) 
B 
1 
NES 
D 
S 
O 
B e 
Nu ~ 
i /  
Passive NES NESmut 
NLS NLS 
Figure 6. Fusion Protein Containing both NES and NLS Is Localized 
in Both Nucleus and Cytoplasm with Slightly Stronger Nuclear Fluores- 
cence 
(A) (a) and (d) are schematic representations of the fusion proteins. 
The oligonucleotides that specify the SV40 large T antigen NLS were 
introduced into the C-termini of wild-type NES-GST (H6-PKla(35-49)- 
GST) (a, b, and c) and mutant NES-GST (H6-PKI(~(35-49)mu,-GST) 
(d, e, and f). The fusion proteins were injected either in the cytoplasm 
(b, e) or in the nucleus (c, f). The injected cells were fixed 45 min after 
injection. The results are summarized. N, nuclear; C, cytoplasmic. 
(B) Nuclear/cytoplasmic fluorescence intensity ratios are plotted for 
NES-containing proteins (e.g., the complex of FITC-labeled C subunit 
with PKI), proteins passively equilibrated between nucleus and cyto- 
plasm (10 kDa dextran, C subunit of cAPK), protein containing both 
NES and NLS (NES-GST-N LS), and protein containing defective NES 
and functional NLS (NES~,t-GST-NLS). All the ratios were measured 
by fluorescence imaging 45 min after injection, 
injection. The quantitative nuclear/cytoplasmic ratio was 
44 - 20 (Figure 6B). These results suggest that an intact 
NES is almost but not quite as strong as an NLS and 
confirm the importance of Leu-41 and Leu-44 in the NES. 
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Sequence Containing Only the Ten Residues 37-46 
Is Sufficient for Nuclear Export 
Knowing that hydrophobic but not hydrophilic residues are 
crucial, we then investigated whether the sequence 37- 
46 of PKI~, which contains all the critical hydrophobic resi- 
dues but not he flanking hydrophilic residues, is sufficient 
for nuclear export. The sequence corresponding to the 
region 37-46 of PKI~ was fused to the C-terminus of GST, 
and the chimeric protein was then microinjected into either 
the nucleus or the cytoplasm. The fusion protein was ex- 
cluded from the nucleus 30 min after injection (Figure 7A). 
Thus, a sequence as short as 10 residues encodes an 
NES, which is separated from the PKI inhibitory region 
(5-24). Therefore, PKI utilizes two distinct domains to 
achieve different biological functions, kinase inhibition and 
nuclear export (Figure 8). 
The Effector Domain of HIM-1 Rev Protein Is Also 
Sufficient to Export GST Fusion Protein 
from the Nucleus 
Human immu nodeficiency virus type 1 (H IV-l) Rev protein 
is an RNA-binding protein containing two essential func- 
tional domains. The N-terminal domain is necessary and 
sufficient for RNA binding, multimerization of protein, and 
nuclear localization (Bohnlein et al., 1991 ; Hammerschmid 
et al., 1994; Malim et al., 1989). The C-terminal domain 
is the effector domain, which is rich in leucine residues 
(Malim et al., 1991; Venkatesh and Chinnadurai, 1990) 
(Figure 8). The effector domain has been shown to be 
A Export 
GST-PKI(37 46) ~/'///'///////~////////'/////////////~-RGB-~-GB + 
GST PK1(37+46) 
Expo~ 
B 
v////////////////////////////////~ ~ RGS GS + ~ST-R.v(~3 ~4) P//i,///+,'-H/.,++,/..z.,+.,+.,/..'+.'//+.,++,/,'+..'+.,~-__-i-~---="'"~F-- 
GST Rev(73-84) 
RGS GS GST-m o(73-8~) F//////////////////////////~////~--~-__ 
GST MI0(73-B4) 
Figure 7. The Effector Domain of HIV-1 Rev Protein Shares Some 
Similarity to NES of PKI 
(A) Ten residues of PK1(~(37-46) are sufficient for nuclear export. An 
oligonucleotide specifying PKIc~(37-46) was fused to the C-terminus 
of GST, and the distribution of GST-PKI~(37-46) was examined 30 
rain after nuclear injection. 
(B) Residues 73-84 from HIV-1 Rev protein are also sufficient for 
nuclear export. Oligonucteotides specifying wild-type and mutant 
Rev(73-84) were fused to the C-terminus of GST. The mutated resi- 
dues are underlined. The export abilities of wild-type and mutant GST- 
Rev(73-84) were examined 30 min after nuclear injection. 
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Figure 8. Comparison of Functional Domains between PKI and Rev 
PKI has two separate and distinct functional domains, a kinase inhibitor 
site at the N-terminus and an NES near the C-terminus. HIV-1 Rev 
protein also contains two functional domains. The N-terminal domain 
is necessary and sufficient for RNA binding and nuclear localization. 
The C-teminal domain is necessary and sufficient for nuclear export. 
The functional domains from both PKI and Rev are boxed. Critical 
residues are in bold. 
required for the export of pre-mRNAs that are essential 
for completion of the HIV-1 life cycle (Fischer et al., 1994). 
Mutations in the effector domain significantly impaired the 
export ability of this protein and result in a trans-dominant 
phenotype (Malim et al., 1989; Venkatesh and Chinna- 
dural, 1990). The sequence in this leucine-rich domain 
(LQLPPLERLTLD) is similar to the NES derived from PKI 
(LALKLAGLDIN), especially the last three leucines or iso- 
leucines (underlined). Mutation of individual eucines to 
alanine prevented exit from the nucleus and destroyed 
biological activity (Meyer and Malim, 1994). The similarity 
of the sequences between NES of PKI and effector domain 
of Rev protein, as well as the capability of effector domain 
of Rev to export pre-mRNA from the nucleus, led us to 
test whether this effector domain is sufficient for nucleus 
export. To do this, the sequence from 73-84 of the Rev 
effector domain (LQLPPLERLTLD) was fused to GST (see 
Figure 7B). The fusion protein was then injected into the 
nucleus. The result revealed that this sequence is suffi- 
cient to direct the fusion protein from the nucleus to the 
cytoplasm. In contrast, a mutant form sequence (M10), 
with Leu-78 and Glu+79 replaced with Asp-78 and Leu-79, 
respectively, failed to export the fusion protein. This is 
consistent with the previous result that M10 is defective 
in exporting pre-mRNA from the nucleus. Therefore, in 
addition to PKI, Rev protein utilizes a similar hydrophobic 
motif to achieve the nuclear export of pre-mRNA. 
Discussion 
Compared with protein import, protein export from the nu- 
cleus has been poorly understood; this description of an 
NES that causes nontrafficking proteins to be exported 
from the nucleus is novel. This study has identified an 
NES, a short amino acid sequence in which hydrophobic 
residues are critical. This signal causes an ATP- and tem- 
perature-dependent extrusion from the nucleus that is 
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much more rapid and complete than previous examples 
of default shuttling of proteins bearing only an NLS 
(Schmidt-Zachmann et al., 1993; Laskey and Dingwall, 
1993). In the latter case, most of the shuttling molecules 
are in the nucleus at any moment, but their occasional 
escape on a time scale of hours can be detected by sensi- 
tive trapping assays. By contrast, a protein displaying a 
functional NES is predominantly cytoplasmic at steady 
state and reaches that distribution within minutes after 
direct microinjection into the nucleus. Even proteins such 
as BSA or IgG, which are far too large to diffuse through 
nuclear pores, undergo net extrusion when conjugated to 
a functional N ES (Borer et al., 1989; Goldfarb et al., 1986; 
Guiochon et al., 1991; Lanford et al., 1986). These results 
reconfirm that NES action cannot be explained by prefer- 
ential binding to cytoplasmic rather than nuclear compo- 
nents, because such binding could only affect proteins 
that could cross the nuclear envelope. 
Self-Sufficiency of the NES 
Fusing the candidate NES to two unrelated proteins, GST 
and R'(A1-91), and also the chemical conju~]ations ofsyn- 
thetic NES peptide to BSA and IgG, was sufficient o in- 
duce export and exclusion from the nucleus. Moreover, 
fusing the NES to three different regions of GST gave 
similar results. These results suggest that the NES, like 
the NLS, is directly encoded by a short peptide rather than 
by a ternary structure generated by inducing changes in 
the conformation of the attached protein or juxtaposing 
other regions. The only case where the NES did not cause 
nuclear export and exclusion is native uncomplexed PKI 
itself, which readily enters the nucleus. The NES only ap- 
pears to be exposed when the N-terminus of PKI binds to 
the C subunit (Fantozzi et al., 1994). Fusion of the N-ter- 
minus to GST or MBP is also sufficient o restore nuclear 
export (Wen et al., 1994). Because these three partner 
proteins share no structural similarity, the most likely ex- 
planation for their common action is th;~t he NES is 
masked by the N-terminus of PKI until the latter is itself 
engaged in some other interaction (Wen et al., 1994). The 
C-terminus of native PKI may also assist in the masking 
of the NES, because fusion of the C-terminus to GST also 
activates export. 
Sequence Specificity of the NES 
Truncation analysis showed that the 15-mer PKla(35-49) 
was a functional NES when fused to GST and R'(A1-91) 
or conjugated to BSA and IgG. Preliminary results showed 
that just the ten residues 37-46 are sufficient for nuclear 
export. Alanine-scanning mutagenesis howed that no in- 
dividual hydrophilic residue was necessary, not even Lys- 
40, which is conserved between PKI~ and PKII31. However, 
hydrophobic residues Ile-46, Leu-44, Leu-41, Leu-37, and 
possibly Leu-39 are required for a fully functional NES. 
Leu-37, Leu-41, and Leu-44 are known from solution NMR 
studies and secondary structure prediction to form a hy- 
drophobic surface of a helix extending from residues 35 
to 44 (A. Padilla et al., personal communication). Ile-46 
lies just beyond the helix. These residues might fit together 
to form a hydrophobic surface recognized by the export 
apparatus. PKII31 has Val-46 instead of Ile-46, so at least 
one minor alteration seems acceptable as long as suffi- 
cient hydrophobicity is retained. These results also docu- 
ment the sequence specificity of the NES. Further studies 
will be necessary to determine whether other substitutions 
less drastic than alanine are tolerated at the key hydropho- 
bic residues. 
Do Any Other Molecules Use the Same NES 
or Export Machinery? 
The sequence from the effector domain of HIV-1 Rev pro- 
tein is also sufficient o export a GST fusion protein from 
the nucleus. Although the sequences in PKI (LAL- 
KLAGLDIN) and Rev (LQLPPLERLTLD) are not identical, 
they show great similarity. Both sequences are rich in hy- 
drophobic residues, the last three of which are especially 
critical for nuclear export. However, the two underlined 
sequences alone are not sufficient for nuclear export (data 
not shown). The first two leucines might also contribute 
to the full nuclear export activity as they do in PKI. Another 
interesting molecule that appears to contain the NES-like 
sequence derived from PKI is IKBa (Haskill et al., 1991). 
However, it remains an open question whether the NES 
of PKI is representive of a general signal for nuclear export. 
It will be interesting, furthermore, to examine to what ex- 
tent the pathway for PKI-mediated export and RNA export 
overlap. 
Nuclear Export versus Nuclear Import 
The protein containing both NES and NLS can transport 
in either direction and reaches an equilibrium, indicating 
that neither is overwhelming. Although the protein is 
slightly concentrated in the nucleus, suggesting that the 
NLS is relatively a little stronger than the NES, the final 
distribution may be d~termined by the rates of these two 
processes and could also be influenced by binding pro- 
teins in either compartment. Since the NLS is very basic, 
while the NES is very hydrophobic, these two motifs very 
likely target different sites to achieve translocation. On the 
other hand, both NLS- and NES-mediated processes are 
temperature and ATP dependent, and a similar mecha- 
nism may be involved in both processes. An important 
question to be addressed now is to what extent, if any, 
the machineries of nuclear import and export are shared. 
Biological Significance 
What is the biological purpose of a system for actively 
extruding RNA-free proteins from the nucleus? Proteins 
are synthesized in the cytoplasm, so if it is important for 
a particular protein to remain permanently cytoplasmic, 
a simpler strategy would be to keep it from entering the 
nucleus in the first instance, by increasing its size beyond 
the limit for passive diffusion, binding it to other cyto- 
plasmic components, or avoiding NLSs. An NES would be 
most valuable when a protein has to be rapidly transported 
from the nucleus either to participate in a catalytic cycle 
or in response to changing conditions such as the cell 
cycle or modulations of external stimuli. In the former case, 
the NES would probably be combined with an NLS; in the 
latter, it should be possible to mask or unmask the NES 
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as required.  Whi le  the constructs  descr ibed  in the present  
work  prov ide examples  of  both, the ful l - length PKI ex- 
pressed in cel ls  prov ides an example  of an NES that  is 
on ly  exposed  when PKI is bound to C, and thus suggests  
a poss ib le  role for  PKI in e ject ing C subunit  f rom the nu- 
c leus to ensure  the cell cycle progress ion (Wen et al., 
1995). Other  examples  of NES-conta in ing pept ides  remain  
to be identif ied. 
Experimental Procedures 
Site-Directed Mutagenesis 
Mutations in PKla were introduced as described by Kunkel (1985). 
The PKla cDNA was provided to us by Dr. R. Maurer (Thomas et al., 
1991). All mutants were verified by sequencing and expressed in E. 
coil BL21(DE3) (Lysis). 
Construction of Fusion Proteins 
Construction of Deletion Fusion Proteins with GST 
The N-terminal deletions of PKt (25-75, 35-75, and 44-75) were fused 
in-frame to pGEX-KG vector to generate GST-PKI fusion constructs. 
The C-terminal deletions of PKla (1-56, 1-49, and 1-42) were fused 
to the N-terminus instead of the conventional C-terminus of GST to 
generate PKI-GST fusion constructs, because the latter fusions were 
consistently contaminated by small proteins, most likely owing to the 
proteolysis of PKI caused by C-terminal truncations. A vector, 
pRSETB-GST, which contains multiple cloning sites proceeding the 
N-terminus of GST, was constructed and used to this end. 
Construction of Fusion Proteins Containing Short 
Sequences of PKI with GST 
Synthetic oligonucleotides that specify short sequences of PKI were 
fused to either the N-terminus or the C-terminus of GST to generate 
Hs-PKla(35-56)-GST, H6-PKla(35-49)-GST, HrPKla(35-44)-GST, 
PKla(35-49)-GST, GST-PKIa(35-49), and GST-PKla(37-46) con- 
stucts. 
Construction of Fusion Proteins with Regulatory 
Subunit (Type I, R~ 
Monomeric R ~ subunit mutant cDNA (W(A1-91)) was introduced into 
the C-termini of H6-PKla(35-49) and Hs-PKla(35-44) constructs to 
form H6-PKla(35-49)-RJ(A1-91) and HrPKla(35-44)-R'(A1-91). 
Construction of Fusion Proteins Containing 
Both NLS and NES 
A synthetic oligonucleotide corresponding to SV40 large T antigen 
NLS (PKKKRKVEDP) (Kalderon et al,, 1984) was fused to the C-termini 
of H~-PKla(35-49)-GST and Hs-PKla(35-49)mut-GST, where Leu-41 
and Leu-44 were replaced with alanines, to form Hs-NES-GST-NLS 
and H6-PKla(35-49)m~,-GST-N LS, 
Construction of GST Fusion Proteins Containing 
Sequences of HIV.1 Rev Protein 
Synthetic oligonucleotides specifying wild-type and mutant sequences 
of Rev(73-84) were fused to PGEX-KG to create GST-Rev(73-84) and 
GST-M10(73-84) constructs. 
Preparation of Proteins 
All fusion proteins containing a GST portion were purified on glutathi- 
one-agarose colu runs as described previously (Guan and Dixon, 1991 ; 
Harootunian et al., 1993; Wen et al., 1994). R ~ fusion proteins were 
purified by metal (Ni ~) chelate chromatography (Qiagen, Incorporated) 
as described by the manufacturer for polyhistidine fusion protein purifi- 
cation. Recombinant C subunit and PKI were expressed and purified 
as described previously (Wen and Taylor, 1994). 
Fluorescence Labeling of Purified Protein 
All the fusion proteins were labeled with FITC as described earlier and 
further purified on the Superose 12 column (Fantozzi et al., 1994; Wen 
and Taylor, 1994). All the complexes of mutant PKIs with FITC-labeled 
C subunit were purified on a Sephadex 75 column with a Pharmacia 
fast protein liquid chromatography instrument. All the labeled proteins 
were then concentrated to 60-100 p.M. 
Conjugation of Synthetic Peptides to Carrier Protein 
Synthetic peptide P(35-49) encompassing PK1(35-49) (GSNELAL- 
KLAGLDINKTGGC-NH2) and mutant peptide P(35-49)m,t (GSNELAL- 
KAAGADINKGGC-NH2), where Leu-41 and Leu-44 were replaced with 
alanines, were synthesized on a Milligen 9050 Pepsyn peptide synthe- 
sizer according to standard Fmoc methodology. Both peptides were 
purified by HPLC, and the sequences were confirmed by a gas phase 
amino acid sequencer with an on-line phenylthiohydantoine analyzer 
(Applied Biosystems, Incorporated, models 470A and 120). The syn- 
thetic peptides were conjugated to BSA and rabbit IgG with the bifunc- 
tional cross-linking reagent SMCC (Molecular Probes). SMCC in di- 
methylformamide was added to the carrier protein (1 mg/ml) in 10 mM 
potassium phosphate buffer (pH 7.0), with 25:1 molar ratio of SMCC 
and carrier protein. After incubation for 45 rain at room temperature, 
the unreacted SMCC was removed by prepacked gel filtration column 
NAP-10 (Pharmacia) in the same buffer. The SMCC-coupled carrier 
proteins (1 mg/ml in the same buffer) were combined with peptides 
with 25:1 molar ratio of peptide and carrier protein and incubated for 
3 hr at room temperature. The unconjugated peptide was removed 
by using a prepacked NAP-10 column. The conjugates of BSA (P(35- 
49)-BSA, P(35-49)mo,-BSA) were then labeled with FITC in 10 mM 
potassium phosphate buffer (pH 7.0). All the conjugations were ana- 
lyzed by SDS-polyacrylamide gel to ensure a satisfactory coupling ratio. 
Cells, Mlcroinjection, and Fluorescence Imaging 
Culture of REF52 cells, microinjection, and fluorescence imaging were 
performed under the same conditions as described previously (Fan- 
tozzi et al., 1994; Harootunian et al., 1993; Wen et al., 1994). 
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